Liquidia (LQDA) Times Interest Earned (2020 - 2026)
Liquidia's (LQDA) quarterly Times Interest Earned came in at $0.23 in Q1 2026, up 157.46% year-on-year from $0.09 in Q1 2025, and down 92.04% quarter-over-quarter from $2.87 in Q4 2025.
Liquidia (LQDA) Times Interest Earned (2020 - 2026) Analysis & Trends
Liquidia's Times Interest Earned history runs 7 years deep, the most recent figure standing at $0.23 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 157.46% year-over-year to $0.23 in Q1 2026; TTM through Mar 2026 was $0.17, a 111.79% increase from a year earlier, with the FY2025 full-year figure at -$0.21, up 80.43% from the prior year.
- Times Interest Earned declined to $0.23 in Q1 2026 per LQDA's latest filing, from $2.87 in the prior quarter.
- Across five years, Times Interest Earned topped out at $6.69 in Q4 2023 and bottomed at -$10.67 in Q1 2022.
- The 5-year median for Times Interest Earned is -$0.55 (2025), against an average of -$1.47.
- Across the five-year window, Times Interest Earned plunged 761.39% in 2022 and soared 171.88% in 2023, its largest moves.
- Year by year, Times Interest Earned stood at -$9.31 in 2022, then soared by 171.88% to $6.69 in 2023, then slumped by 219.73% to -$8.01 in 2024, then jumped by 135.8% to $2.87 in 2025, then plunged by 92.04% to $0.23 in 2026.
- Per Business Quant, the three latest LQDA Times Interest Earned figures stand at $0.23 (Q1 2026), $2.87 (Q4 2025), and $0.01 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.23 |
| Dec 31, 2025 | 2.87 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.40 |
| Dec 31, 2024 | -8.01 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | 6.69 |
| Sep 30, 2023 | -0.87 |
| Jun 30, 2023 | -0.74 |
| Mar 31, 2023 | -0.41 |
| Dec 31, 2022 | -9.31 |
| Sep 30, 2022 | -0.81 |
| Jun 30, 2022 | -1.65 |
| Mar 31, 2022 | -10.67 |
| Dec 31, 2021 | -55.70 |
| Sep 30, 2021 | -1.06 |
| Jun 30, 2021 | -3.94 |